Tech & Pharma
Takeda has decided to terminate the development activities for fasiglifam, an investigational treatment for type II diabetes, due to concerns about liver safety.
Vapourtec and Nanjing University of Technology have agreed to establish a flow chemistry research lab in China.
Sihuan Pharmaceutical has signed an agreement with to-BBB to combine drug compounds and brain drug delivery technology for a research study.
A free and open-source public resource aims to bring much-needed transparency to the murky and contentious world of gene patenting.
Senhwa Biosciences has raised an additional US$17 million in Series B financing to drive its anticancer agents through critical clinical trials.
Echo Therapeutics, Inc. has granted Medical Technologies Innovation Asia, Ltd. rights to commercialize Echo’s Symphony CGM System in China.
Omron Healthcare will exclusively distribute NeuroMetrix’s point-of-care test for early detection of diabetic peripheral neuropathy in China.
ScinoPharm has completed construction of its Changshu plant on a 16-acre site in China.
A*STAR and KHIDI have signed a MOU to symbolize their growing bilateral cooperation in the field of biomedical sciences.
Strand Life Sciences is collaborating with El Camino Hospital to open a Strand Center for Genomics and Personalized Medicine in San Francisco, US.